Erythropoietin reduces Schwann cell TNF-α, Wallerian degeneration and pain-related behaviors after peripheral nerve injury

被引:77
作者
Campana, WM [1 ]
Li, XQ
Shubayev, VI
Angert, M
Cai, K
Myers, RR
机构
[1] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA
[2] VA Healthcare Syst, San Diego, CA USA
[3] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA
关键词
glial activation; neuropathic pain; rat; real time PCR; Schwann cell;
D O I
10.1111/j.1460-9568.2006.04606.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic sciatic nerve constriction injury (CCI) induces Wallerian degeneration and exaggerated pain-like behaviors. These effects are mediated in large part by pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-alpha). In this study, we demonstrate that systemically administered recombinant human erythropoietin (rhEpo) facilitates recovery from chronic neuropathic pain associated with CCI in rats. Because TNF-alpha has been implicated in the development of pain-related behaviors, we measured TNF-alpha mRNA at the nerve injury site. Systemically or locally administered rhEpo decreased TNF-alpha mRNA, compared with that observed in untreated animals. RhEpo also significantly (P < 0.05) decreased axonal degeneration. Immunohistochemistry of CCI nerve showed abundant TNF-alpha in Schwann cells, axoplasm and macrophages. In rhEpo-treated animals, TNF-alpha immunopositivity was decreased selectively in Schwann cells. These results suggest a model in which rhEpo counteracts the effects of TNF-alpha in CCI by blocking expression of TNF-alpha in Schwann cells. To further test this model, we studied primary Schwann cell cultures. RhEpo inhibited TNF-alpha expression in response to lipopolysaccharide, supporting the conclusions of our in vivo CCI experiments. In addition, rhEpo directly counteracted Schwann cell death induced by exogenously added TNF-alpha in vitro. These results indicated that rhEpo regulates TNF-alpha by multiple mechanisms; rhEpo regulates TNF-alpha mRNA expression by Schwann cells but also may directly counteract TNF-alpha signaling pathways that lead to injury, chronic pain and/or death.
引用
收藏
页码:617 / 626
页数:10
相关论文
共 58 条
[31]   THE ROLE OF FOCAL NERVE ISCHEMIA AND WALLERIAN DEGENERATION IN PERIPHERAL-NERVE INJURY PRODUCING HYPERESTHESIA [J].
MYERS, RR ;
YAMAMOTO, T ;
YAKSH, TL ;
POWELL, HC .
ANESTHESIOLOGY, 1993, 78 (02) :308-316
[32]   Inhibition of p38 MAP kinase activity enhances axonal regeneration [J].
Myers, RR ;
Sekiguchi, Y ;
Kikuchi, S ;
Scott, B ;
Medicherla, S ;
Protter, A ;
Campana, WM .
EXPERIMENTAL NEUROLOGY, 2003, 184 (02) :606-614
[33]   Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture [J].
Nagai, A ;
Nakagawa, E ;
Choi, HB ;
Hatori, K ;
Kobayashi, S ;
Kim, SU .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (04) :386-392
[34]   Cytokine-induced cell death in immortalized Schwann cells: roles of nitric oxide and cyclic AMP [J].
Nagano, S ;
Takeda, M ;
Ma, L ;
Soliven, B .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (06) :1486-1495
[35]   Effects of neutralizing antibodies to tumor necrosis factor-alpha on nucleus pulposus-induced abnormal nociresponses in rat dorsal horn neurons [J].
Onda, A ;
Yabuki, S ;
Kikuchi, S .
SPINE, 2003, 28 (10) :967-972
[36]   A new mathematical model for relative quantification in real-time RT-PCR [J].
Pfaffl, MW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (09) :E45
[37]   In vivo evidence that erythropoietin protects neurons from ischemic damage [J].
Sakanaka, M ;
Wen, TC ;
Matsuda, S ;
Masuda, S ;
Morishita, E ;
Nagao, M ;
Sasaki, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4635-4640
[38]  
Schäfers M, 2003, J NEUROSCI, V23, P2517
[39]   Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice [J].
Schäfers, M ;
Brinkhoff, J ;
Neukirchen, S ;
Marziniak, M ;
Sommer, C .
NEUROSCIENCE LETTERS, 2001, 310 (2-3) :113-116
[40]  
SCHAFERS M, 2002, J NEUROSCI, V17, P791